BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Yang G, Song M, Hoang DH, Tran QH, Choe W, Kang I, Kim SS, Ha J. Melatonin prevents doxorubicin-induced cardiotoxicity through suppression of AMPKα2-dependent mitochondrial damage. Exp Mol Med 2020;52:2055-68. [PMID: 33339952 DOI: 10.1038/s12276-020-00541-3] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
Number Citing Articles
1 Reiter RJ, Sharma R, Rodriguez C, Martin V, Rosales-Corral S, Zuccari DAPC, Chuffa LGA. Part-time cancers and role of melatonin in determining their metabolic phenotype. Life Sci 2021;278:119597. [PMID: 33974932 DOI: 10.1016/j.lfs.2021.119597] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
2 Arinno A, Maneechote C, Khuanjing T, Ongnok B, Prathumsap N, Chunchai T, Arunsak B, Kerdphoo S, Shinlapawittayatorn K, Chattipakorn SC, Chattipakorn N. Cardioprotective effects of melatonin and metformin against doxorubicin-induced cardiotoxicity in rats are through preserving mitochondrial function and dynamics. Biochem Pharmacol 2021;192:114743. [PMID: 34453902 DOI: 10.1016/j.bcp.2021.114743] [Reference Citation Analysis]
3 Rawat PS, Jaiswal A, Khurana A, Bhatti JS, Navik U. Doxorubicin-induced cardiotoxicity: An update on the molecular mechanism and novel therapeutic strategies for effective management. Biomed Pharmacother 2021;139:111708. [PMID: 34243633 DOI: 10.1016/j.biopha.2021.111708] [Cited by in Crossref: 3] [Article Influence: 3.0] [Reference Citation Analysis]
4 Kim CW, Choi KC. Effects of anticancer drugs on the cardiac mitochondrial toxicity and their underlying mechanisms for novel cardiac protective strategies. Life Sci 2021;277:119607. [PMID: 33992675 DOI: 10.1016/j.lfs.2021.119607] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]